Machine Learning Envisagenics, Cancer Research Horizons, and Queen Mary University of London Announce Strategic… AIT News Desk Dec 13, 2022 Envisagenics, an AI-driven biotechnology company that delivers therapies for RNA splicing diseases, announced a research collaboration agreement with…
Machine Learning Envisagenics Announces Research Collaboration with Bristol Myers Squibb AIT News Desk Nov 29, 2022 Envisagenics, an Artificial Intelligence (AI)-driven biotechnology company that delivers therapies for RNA splicing diseases, announced a research…